Trial Profile
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Undergoing Elective Total Hip Arthroplasty
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Landogrozumab (Primary)
- Indications Muscular atrophy
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 04 Dec 2014 New trial record